72
T. Yamane et al. / Tetrahedron Letters 45 (2004) 69–73
Yotsutsuji, A.;Sakai, H. Jpn. Kokai Tokkyo Koho
O
O
JP62178590, 1987; Chem. Abstr. 1988, 108, 112450.
4. Cornwall, P.;Dell, C. P.;Knight, D. W. J. Chem. Soc.,
Perkin Trans. 1 1991, 2417–2428, and references cited
therein.
5. Okonya, J. F.;Hoffmann, R. V.;Johnson, M. S. J. Org.
Chem. 2002, 67, 1102–1108, and references cited therein.
6. (a) Goto, Y.;Yamazaki, M.;Hamana, M. Chem. Pharm.
Bull. 1971, 19, 2050–2057;(b) Dalley, N. K.;Petrie, C. R.,
III, Revankar, G. R.;Robins, R. K. Nucleos. Nucleot.
1985, 4, 651–659.
H
N
N
N
N
X
S
S
O
R
R
O
X
X
N
N
X
S
S
7. Vernin, G.;Aune, J. P.;Dou, H. J. M.;Metzger, J. Bull.
Soc. Chim. Fr. 1967, 4523–4533.
R
R
(X = Cl, Br)
8. Mohanazadeh, F. Int. J. Chem. 1995, 6, 73–77; Chem.
Abstr. 1996, 125, 221682.
Scheme 4. Proposed reaction mechanism.
9. Wollowitz, S.;Isaacs, S. T.;Rapoport, H.;Spielmann, H.
P.;Nerio, A. U.S. Patent 5,625,079, 1997.
10. (a) Chao, E. Y.;Haffner, C. D.;Lambert, M. H.;
Maloney, P. R.;Sierra, M. L.;Sternbach, D. D.;
Sznaidman, M. L.;Willson, T. M.;Xu, H. E.;Gellibert,
F. J. Patent WO 01/00603 A1, 2001; Chem. Abstr.
2001, 134, 86235;(b) Hubacher, K. Liebigs Ann. Chem.
application of these methodologies to other substrates
such as oxazoles is under investigation in the laboratory.
1890, 259, 228–253;(c) Simiti, I.;Muresan, A.
rev.
Roum. Chim. 1976, 21, 1073–1081; Chem. Abstr. 1997,
86, 29697.
11. The desired compound and its regioisomer are discrimi-
nated apparently by their differences of chemical shifts on
1H and 13C NMR.
12. HPLC conditions: YMC Pack-SIL A-002 column with
40:1 n-hexane/THF as mobile phase. To investigate
regioselectivity, we used HPLC analysis with the normal
phase. The 4-methyl-5-halomethyl regioisomers easily
decomposed during HPLC analysis with the reverse
phase.
Acknowledgements
We thank Ms. K. Higashikawa and Mr. A. Fujishima
for single-crystal X-ray structural analyses, and Dr.
Kiminori Tomimatsu and Mr. Mitsuhisa Yamano for
helpful discussions.
13. Compound 1 in a free form is liquid at an ambient
temperature.
References and Notes
14. General procedure for the preparation of compound 2. To a
solution of 4,5-dimethyl-2-phenyl-1,3-thiazole hydrochlo-
rate (1ÆHCl, 13.3 mmol) in acetonitrile (·10 v/w of 1ÆHCl),
triethylamine (13.3 mmol) was added dropwise at rt, and
the reaction mixture was stirred at 60 ꢁC for 2 h, then
allowed to cool to rt. To the mixture was added NCS
(13.3 mmol) and the reaction mixture was stirred at 60 ꢁC
for 2 h, then allowed to cool to rt. Water (·5–10 v/w of
1ÆHCl) was added to the reaction mixture dropwise at rt
to give colourless to pale yellow precipitation. The
mixture was stirred at 0–5 ꢁC for 1 h. The precipitation
was filtered and washed with ice-cooled acetonitrile–water
(1:1, v/v) (·2 v/w of 1ÆHCl) to afford the corresponding
chloride 2.
15. Data for 4-(chloromethyl)-5-methyl-2-phenyl-1,3-thiazole
(Table 1, entry 1). Colourless crystal: mp 86–88 ꢁC. 1H
NMR (CDCl3): d 2.53 (s, 3H), 4.72 (s, 2H), 7.39–7.44 (m,
3H), 7.87–7.90 (m, 2H). 13C NMR (CDCl3): d 11.4, 38.9,
126.3, 128.9, 129.9, 132.5, 133.4, 148.6, 164.7. IR (KBr,
cmÀ1): 1468, 1259, 764, 687, 654, 623. LRMS (EI): m=z
223 (Mþ). HRMS (EI): Calcd for C11H10ClNS (M):
223.0222. Found: 223.0257. Anal. Calcd for C11H10NSCl:
C, 59.05;H, 4.51;N, 6.26;S, 14.33;Cl, 15.85. Found: C,
58.95;H, 4.35;N, 6.26;S, 14.39;Cl, 15.81.
1. For reviews, see: (a) Dondoni, A.;Merino, P. In
Comprehensive Heterocyclic Chemistry II;Shinkai, I.,
Ed.;Katritzky, A. R., Rees, C. W., Scriven, E. F. V., Eds.
in Chief;Elsevier: Tarrytown, 1996;Vol. 3, pp 373–474;
(b) Metzger, J. V. In Comprehensive Heterocyclic Chem-
istry;Potts, K. T., Ed.;Katritzky, A. R., Rees, C. W.,
Eds. in Chief;Pergamon: Elmsford, 1984;Vol. 6, pp 235–
331;(c) Vernin, G. In The Chemistry of Heterocyclic
Compounds;Metzger, J. V., Ed.;Weissberger, A., Taylor,
E. C., Eds. in Chief;John Wiley & Sons: New York, 1979;
Vol. 34, Part 1.
2. (a) Al Hariri, M.;Jouve, K.;Pautet, F.;Domard, M.;
Fenet, B.;Fillion, H. J. Org. Chem. 1997, 62, 405–410;(b)
Al Hariri, M.;Galley, O.;Pautet, F.;Fillion, H.
Eur. J.
Org. Chem. 1998, 593–594;(c) Jouve, K.;Pautet, F.;
Domard, M.;Fillion, H. Chem. Pharm. Bull. 1999, 47,
1064–1067.
3. (a) Boehringer, M.;Hunziker, D.;Kuehne, H.;Loeffler,
B. M.;Sarabu, R.;Wessel, H. P. Patent WO 03/037327
A1, 2003; Chem. Abstr. 2003, 138, 368754;(b) Bach, A. T.;
Kapa, P. K.;Lee, G. T.;Loeser, E. M.;Sabio, M. L.;
Stanton, J. L., Vedananda, T. R. Patent WO 03/043985
A1, 2003; Chem. Abstr. 2003, 139, 6767;(c) Momose, Y.;
Maekawa, T.;Yamano, T.;Kawada, M.;Odaka, H.;
Ikeda, H.;Sohda, T. J. Med. Chem. 2002, 45, 1518–1534;
(d) Deorazio, R. J.;Nikam, S. S.;Scott, I. L.;Sherer, B.
A. European Patent EP 1 251 128 A1, 2002; Chem. Abstr.
2002, 137, 310908;(e) Momose, Y.;Maekawa, T.;Odaka,
H.;Ikeda, H.;Sohda, T. Chem. Pharm. Bull. 2002, 50,
100–111;(f) Takano, S.;Imaizumi, H.;Kajita, T.;
Takasima, K.;Takezawa, K.;Yotsutsuji, M.;Hoda, T.;
16. HPLC conditions: YMC Pack-ODS A-302 column with
1:1 0.05 M KH2PO4/acetonitrile as mobile phase.
17. General procedure for the preparation of compound 3. To a
solution
of
4,5-dimethyl-2-phenyl-1,3-thiazole
(1,
22.1 mmol) in acetonitrile (·10 v/w of 1) was added
NBS (22.1 mmol) and the reaction mixture was stirred at
25 ꢁC for 2 h. To the reaction mixture, water (·5–10 v/w of
1) was added dropwise at rt to give colourless to pale
yellow precipitation. The mixture was stirred at 0–5 ꢁC